The Future of Precision Oncology in Nuclear Medicine

Register

The National  Steering Committee invites you to join the first National Theranostics Round Table:

The Future of Precision Oncology in Nuclear Medicine

When:
Thursday October 28

Where:
Dame Dorothy Tangney Alcove

Parliament House Canberra

Agenda

9.00am – 9.20am

Welcome

 

9.20am – 10.05am

What is Theranostics? The Australian experience – Imaging and Therapy past, present and future

Professor Rod Hicks (Peter MacCallum Cancer Centre)

Professor Louise Emmett (St Vincents Hospital)

10.05am–10.50am

Clinical trials and innovative technologies.

Professor Nat Lenzo (GenesisCare)

A/Prof Grace Kong (Peter MacCallum Cancer Centre)

Professor Nick Pavlakis (Royal North Shore)

A/Prof Ros Francis (ARTNET)

Prof Kristofer Thurecht (University of Queensland)

Prof Ian Davis (ANZUP)

10.50-11.00am

NET patient experience

Lynda Dunstone, NET patient

11.00am-11.15am

Morning Tea

 

11.15am-12.00pm

Importance of investment now for the future  

Dr David Cade (Telix)

Dr Keith Hansen (GenesisCare)

Dr Simon Puttick (CSIRO)

Greg Santamaria (Cyclotek)

Dr Alan Taylor (Clarity Pharmaceuticals)  

12.00pm-12.30pm

Innovative models of care: common cancer models v rare and less common cancer models

Prof Michael Michael (Peter MacCallum Cancer Centre)

Prof Andrew Scott (Austin Health)

12.30pm-12.40pm

Prostate Patient experience

Dr Paul Davis, Prostate patient

12.40pm-1.25pm

Sovereign capability, future workforce & infrastructure

Shaun Jenkinson (ANSTO)

Prof Dale Bailey 

Dr Geoff Schembri (Australasian Association of Nuclear Medicine Specialists)

1.25pm-1.45pm

Lunch

 

1.45pm-2.40pm

Trade opportunities, industry performers and supply chains

Amanda Rotger MD (ITM Germany)

Dr Alan Taylor (Clarity Pharmaceuticals)

Dr David Cade (Telix)

GMS

Siemens Healthineers

GE Healthcare

2.40pm-3.25pm

Time for a rethink –  HTA framework for the future

Adjunct Prof John Skerritt (Department of Health)

Prof Andrew Wilson (PBAC)

Prof Robyn Ward (MSAC)

Prof Dorothy Keefe (CEO – Cancer Australia) 

3.25pm-4.00pm

Solutions – moderated panel discussion

Prof Dorothy Keefe (CEO-Cancer Australia)

Dr Mike Freelander MP (Member for Macarthur, NSW)

Dr Katie Allen MP (Member for Higgins, VIC)

Simone Leyden (CEO NECA)

 Prostate Cancer Australia

TGA, PBAC, MSAC

Prof Rod Hicks

4:00pm

Closing statement

Hon Mark Butler, Shadow Minister for Health and Aging

With thanks to:

National Steering Committee

simone-headshot

Simone Leyden

Neuroendocrine Cancer Australia

Prof Rod Hicks

Peter MacCallum Cancer Centre

Prof Michael Michael

Peter MacCallum Cancer Centre

Dale Bailey Cropped

Prof Dale Bailey

Royal North Shore Hospital

Nick Pavlakis Image

Prof Nick Pavlakis

Royal North Shore Hospital

Louise Emmett Image

Prof Louise Emmett

St Vincent's Hospital (Sydney)